Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Screeners that run automatically... and then email you the results! FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Sangamo Therapeutics (SGMO)

Sangamo Therapeutics (SGMO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Sangamo Therapeutics 7000 MARINA BLVD BRISBANE CA 94005 USA

P: 510-970-6000 F: 510-236-8951

Description:

Sangamo Therapeutics, Inc. is a biotechnology company. It focuses on research and development of genomic therapies as well as develops medicines for patient with genetic diseases. The Company's product pipeline includes SB-525, SB-FIX, SB-318, SB-913, SB-728-T and SB-728-HSPC. Sangamo Therapeutics Inc., formerly known as Sangamo BioSciences Inc., is based in Richmond, United States.

Key Statistics

Overview:

Market Capitalization, $K 598,162
Enterprise Value, $K 221,612
Shares Outstanding, K 163,880
Annual Sales, $ 110,700 K
Annual Net Income, $ -178,290 K
Last Quarter Sales, $ 26,460 K
Last Quarter Net Income, $ -53,160 K
60-Month Beta 1.13
% of Insider Shareholders 2.10%
% of Institutional Shareholders 57.53%
Float, K 160,439
% Float 97.90%
Short Volume Ratio 0.17

Growth:

1-Year Return -56.80%
3-Year Return -68.70%
5-Year Return -78.40%
5-Year Revenue Growth 470.91%
5-Year Earnings Growth -20.59%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.34 on 11/03/22
Next Earnings Date N/A
Earnings Per Share ttm -1.19
EPS Growth vs. Prev Qtr -17.24%
EPS Growth vs. Prev Year -3.03%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

SGMO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -53.18%
Return-on-Assets % -27.49%
Profit Margin % -161.06
Net Margin % -324.81
Debt/Equity 0.00
Price/Sales 5.27
Price/Cash Flow N/A
Price/Book 1.80
Book Value/Share 1.97
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar